AlphaLens
Research
研报Overweight4月20日 · Morgan Stanley

Silergy Corp.: Industry/auto demand recovery, and rising server business – but these are largely priced in; EW

Silergy Corp: Post-Cyclical Recovery Priced In Amid Near-Term Margin Pressure

Core Conclusion

The investment case for Silergy has shifted. While clear signs of a cyclical bottom and demand recovery in industrial, automotive, and server/AI segments support our raised earnings estimates and price target to NT$388, these positive developments are largely reflected in the stock’s 36% surge over the past week. Near-term gross margin pressure from 8-inch wafer cost inflation, which the market underappreciates, limits further upside. We downgrade the stock to Equal-weight, advising profit-taking at current levels.

Clear Cyclical Recovery Underway, Led by Industrial and Auto

The analog semiconductor cycle has troughed, setting the stage for Silergy's revenue re-acceleration. Evidence is firming: industry Days of Inventory (DOI) have normalized to a healthy sub-150-day level, and analog ASPs have stabilized and begun to recover in early 2026. Silergy's own demand signals confirm this shift; its initial Q2 2026 wafer demand outlook at foundry partner UMC was revised from flat/down year-over-year to up 10-20% year-over-year, driven by inventory replenishment from Chinese industrial and automotive customers after a 12-month lull. The investment implication is a return to the company's 20-30% annual revenue growth trajectory in 2026, justifying our 2026-2028 EPS estimate increases of 5-13%.

Strong Rally Has Largely Discounted the Upside

The market has rapidly priced in the improving fundamental outlook, diminishing the near-term risk/reward appeal. The stock's 36% gain in one week significantly outpaces the Taiex's 18% rise, reflecting a sharp reassessment of cyclical risks. Our new price target of NT$388, derived from a Residual Income Model, implies only 23x 2027e P/E, offering modest 6% upside from the current price of NT$365.5. The investment takeaway is straightforward: the attractive valuation that existed prior to this move has been eroded, and the stock now appears fairly valued for the visible recovery.

Near-Term Gross Margin Faces Material Pressure from 8-Inch Wafer Costs

The primary near-term headwind, not fully reflected in the stock's optimistic move, is gross margin compression. Over 80% of Silergy's revenue still relies on 8-inch wafers, which are subject to price hikes by foundry partners. The company expects to pass through only a portion of these cost increases to customers. While migration to more economical 12-inch wafers is a long-term positive, the transition takes 1-6 months depending on product qualification, providing no immediate relief. Consequently, the bulk of the margin impact is likely in Q2-Q3 2026. The investment implication is that earnings growth in the coming quarters will be dampened by cost pressure, capping near-term profit expansion and multiples.

Key Risks & Divergences

The primary risk is that persistent consumer end-market weakness offsets the industrial/auto recovery. Further wafer price increases by partners like UMC would exacerbate margin pressure. A slower-than-expected migration to 12-inch wafers would prolong the margin headwind. The key market divergence lies in the balance between the evident cyclical revenue recovery and the underappreciated speed and magnitude of near-term gross margin erosion.

Valuation & Trade Implication

We raise our 12-18 month price target to NT$388 from NT$296 using a Residual Income Model (9.5% cost of equity, 13.5% intermediate growth). This reflects our higher EPS forecasts. However, with the stock price near our target and facing near-term margin headwinds, we downgrade Silergy from Overweight to Equal-weight. The trade implication is to take profits at current levels and await a better entry point or evidence that margin pressures are abating.

Appendix: Key Data

Exhibit 1: Silergy - Estimate Revision Summary

NT$ mnNew '26EOld '26EDiff.New '27EOld '27EDiff.New '28EOld '28EDiff.
Net sales23,69722,7304%28,51826,6797%33,92331,2688%
Operating profit4,1643,76910%6,7475,78517%8,7567,46017%
Diluted EPS (NT$)10.6910.175%16.5914.8811%21.1818.8013%
Operating margin17.6%16.6%23.7%21.7%25.8%23.9%

Exhibit 2: Residual Income Model Framework (Target Price: NT$388) Key Inputs: Cost of Equity: 9.5%, Intermediate Growth: 13.5%, Terminal Growth: 4.5%. Output: Present Value of Forecast Period RI: NT$31,754mn; PV of Continuing Value: NT$80,144mn.

Related (同 ticker)